Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226

Cancer Statistics, 2006

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth M. Ward et al. · CA A Cancer Journal for Clinicians · 2006 · 5.3K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

Anne Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute · 1991 · 3.3K citations

Medicine, Oncology, Pharmacology +11

Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm

Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes et al. · JNCI Journal of the National Cancer Institute · 1989 · 969 citations

Medicine, Biostatistics, Oncology +16

YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1

Eui‐Ju Yeo, Yang‐Sook Chun, Y.-S. Cho et al. · JNCI Journal of the National Cancer Institute · 2003 · 475 citations

Medicine, Oncology, Pharmacology +14

YC-1, a novel activator of platelet guanylate cyclase

FN Ko, Kuo Sc, Lee Fy · Blood · 1994 · 405 citations · Full text

Life Sciences, Biochemistry, Cell Biology +11